Atai stock forecast.

Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.

Atai stock forecast. Things To Know About Atai stock forecast.

If you want to read our detailed analysis of these stocks, go directly to the 10 Best Psychedelic Stocks to Buy Now. 5. Cybin Inc. (OTC: CLXPF) Cybin Inc. (OTC: CLXPF) stock has returned more than ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00. The median estimate represents a +873.45% increase from the last price of 1.13. -15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM - NasdaqGM Real Time Price. Currency in...ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is forecast to be -69.3% in 3 years.

Find the latest AFC Gamma, Inc. (AFCG) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

Find real-time CYBN - Cybin Inc stock quotes, company profile, news and forecasts from CNN Business.Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.

ATAI / ATAI Life Sciences N.V. - Forecast and Price Target https://fintel.io/sfo/us/atai. See More. Bullish. Reply. Keep. Last Read. Share. Copy Message ...Find real-time DNUT - Krispy Kreme Inc stock quotes, company profile, news and forecasts from CNN Business.Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebThe average Compass stock price prediction forecasts a potential upside of 35.39% from the current COMP share price of $2.43. What is COMP's forecast return on equity ... 25. 10. 2023. ... ... Atai in early October, with a price target of $20. Its closing price on Oct. 24 was $1.23. The very same week, Atai announced it had ...

All 39 ARKG ETF Holdings. The portfolio of Cathie Wood updated daily. These are the positions, trades, and weight of all companies in her ARKG Genomic Revolution ETF. Search tickers or categories... Trader's Guide 2024 Ships December 21st.

The average one-year price target for ATAI / ATAI Life Sciences N.V. is $12.572. The forecasts range from a low of $5.151 to a high of $22.05. A stock’s price target is the price at which analysts consider it fairly valued with respect to …

2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...Atai Life Sciences Nv (ATAI) Share Price Forecast. Currently 15 wall-street analysts regularly analyze the financials of Atai Life Sciences Nv on a frequent basis to provide recommendations along with target share price. 15 analysts offering 12-month price forecasts for Atai Life Sciences Nv (ATAI) have a share price target of $12.32.Atai Life Sciences N.V. Market Cap: 184.27M, Enterprise value: 101.26M, P/E: -1.93, PEG ratio: -0.17, EPS: -0.42, Revenue: 334K, EBITDA: -129.47M, ...20. 11. 2023. ... The company's 5Y monthly beta was ticking 0.83. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.65 ...2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.

View the real-time ATAI price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, ...0. These 7 analysts have an average price target of $13.29 versus the current price of ATAI Life Sciences at $1.3447, implying upside. Below is a summary of how these 7 analysts rated ATAI Life ...According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference. September 14, 2023. Press Release.21. 6. 2023. ... Recent price, YTD Change, Market value (mil), Average price target, Implied ... ATAI Life Sciences / ATAI, 1.78, -31.2, 303.8, 12.30, 593. Caribou ...Stock Price Forecast The 5 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 11.00, with a high estimate of 21.00 and a low …Web

(See ATAI stock forecast on TipRanks) SomaLogic . The next Wood pick we’ll look at is a protein biomarker discovery and clinical diagnostics company. SomaLogic operates in what is known as the ...A list of all stock splits on the US stock market in 2023, including both regular (forward) and reverse splits.

What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Real Time Quote from BATS) $1.10 USD 0.00 (0.00%) Updated Nov 27, 2023 10:58 AM ET...The current price was close to the IPO price in September 2020. The $21.81 stock price right now is eight percent lower than the original $23.4 price. There is still hope for recovery if the price does not plunge toward zero. The technical outlook of this stock is pretty much the same as that of Atai. Mind Medicine (MNMD)The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ...Oct 24, 2023 · That said, analysts are starting to come around on ATAI. H.C. Wainwright biotech analyst Patrick Trucchio maintained a "buy" rating on Atai in early October, with a price target of $20. Its ... Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.

Neogenomics Inc. () Stock Market info Recommendations: Buy or sell Neogenomics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Neogenomics share forecasts, stock quote and buy / sell signals below.According to present data Neogenomics's NEO shares and potentially its market environment have …

Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

View a financial market summary for ATAI including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...ATAI Life Sciences N.V. Watch Set a price target alert Premarket Last Updated: Nov 15, 2023 8:18 a.m. EST Delayed quote $ 1.2900 0.04 2.79% Before Hours Volume: 2.23K …WebThe average Bionano Genomics stock price prediction forecasts a potential upside of 532.91% from the current BNGO share price of $1.58. What is BNGO's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.13%.5 Top Websites for Stock Forecasts. Swati Goyal. Story Highlights. When investors talk about top websites for stock forecasts, their focus is on finding the best investment research service. Researching stocks is a major cornerstone of successful investing, and here you’ll find websites that can make your work easy. Share.Their CMPS share price targets range from $19.00 to $120.00. On average, they anticipate the company's stock price to reach $46.83 in the next year. This suggests a possible upside of 683.2% from the stock's current price. View analysts price targets for CMPS or view top-rated stocks among Wall Street analysts.45. Based on our forecast, the price of ATAI will decline by -9.01% over the next 2 weeks and hit $0.95 by Thursday, December 14, 2023. In that time frame, ATAI 's share price is …WebCMPS Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is $50.17 with a high forecast of $120.00 and a low forecast of $21.00. The average price target represents a 832.53% change from the last price of $5.38.Atai Life Sciences (ATAI) Stock Forecast & Price Prediction. Estimation of the future price movement of Atai Life Sciences stock, based on various factors such as historical price …Web

Find real-time CYBN - Cybin Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.04: Annual revenue (last year) $0.00: Annual profit (last year)Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.RPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Oct 24, 2023 · That said, analysts are starting to come around on ATAI. H.C. Wainwright biotech analyst Patrick Trucchio maintained a "buy" rating on Atai in early October, with a price target of $20. Its ... Instagram:https://instagram. fisker car pricestop electric vehicle stocksiphone 15 shipping delaysvaulted app Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.According to 4 stock analysts, the average 12-month stock price forecast for ATAI stock stock is $13.5, which predicts an increase of 1,015.70%. The lowest …Web best investment portfolio management softwareretail reits Find the latest Earnings Report Date for ATAI Life Sciences N.V. Common Shares (ATAI) ... Quarterly Earnings Forecast ... basis and include stock option expenses where possible.Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Super Micro Computer Inc have a median target of 397.00, with a high estimate of 500.00 and a low estimate of 240.00. pet insurance for dogs usaa The average Bionano Genomics stock price prediction forecasts a potential upside of 532.91% from the current BNGO share price of $1.58. What is BNGO's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.13%.The stock ranks in the lowest position of the 53 stocks owned by the ETF. Atai was the third psychedelics company to go public with an IPO in June 2021, following Mind Medicine Inc MNMD and ...Aug 14, 2023 · Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is forecast to be -69.3% in 3 years.